Age at Epstein-Barr virus infection and Epstein-Barr virus nuclear antigen-1 antibodies in Swedish children

Multiple Sclerosis and Related Disorders

Volumn 1, Issue 3, 2012, Pages 136-138

  Simon, K Claire ^a,b   Saghafian Hedengren, Shanie ^c   Sverremark Ekström, Eva ^c   Nilsson, Caroline ^d   Ascherio, Alberto ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d SACHS CHILDREN S HOSPITAL   (Sweden)

Author keywords

Anti EBNA; EBV seroconversion; Epidemiology; Epstein Barr virus; Infectious mononucleosis; Multiple sclerosis

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 1 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

AGE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; HUMAN; IMMUNOFLUORESCENCE; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PATHOGENESIS; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; SEROCONVERSION;

EID: 84860500743     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2012.03.002     Document Type: Article

References (10)

1. A. Ascherio, and K.L. Munger Environmental risk factors for multiple sclerosis. Part I: the role of infection Annals of Neurology 61 2007 288 299 (Pubitemid 46676728)
2. E.D. Kieff, and A.B. Rickinson Epstein-Barr virus and its replication D.M. Knipe, P.M. Howley, D.E. Griffin, Fields virology 5th ed. 2007 Wolters Kluwer Health/Lippincott Williams & Wilkins Philadelphia 2603 2654
3. L.I. Levin, K.L. Munger, E.J. OReilly, K.I. Falk, and A. Ascherio Primary infection with the Epstein-Barr virus and risk of multiple sclerosis Annals of Neurology 67 2010 824 830
4. R.M. Lucas, A.L. Ponsonby, and K. Dear Current and past Epstein-Barr virus infection in risk of initial CNS demyelination Neurology 77 2011 371 379
5. A. Linde, J. Andersson, G. Lundgren, and B. Wahren Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections Journal of Medical Virology 21 1987 109 121 (Pubitemid 17001949)
6. A. Linde, B. Kallin, and J. Dillner Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis Journal of Infectious Diseases 161 1990 903 909 (Pubitemid 20148321)
7. K.L. Munger, L.I. Levin, E.J. OReilly, K.I. Falk, and A. Ascherio Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel Multiple Sclerosis 2011
8. C. Nilsson, A. Linde, and S.M. Montgomery Does early EBV infection protect against IgE sensitization? Journal of Allergy and Clinical Immunology 116 2005 438 444 (Pubitemid 41096556)
9. S. Saghafian-Hedengren, E. Sverremark-Ekstrom, A. Linde, G. Lilja, and C. Nilsson Early-life EBV infection protects against persistent IgE sensitization Journal of Allergy and Clinical Immunology 125 2010 433 438
10. E.L. Thacker, F. Mirzaei, and A. Ascherio Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis Annals of Neurology 59 2006 499 503 (Pubitemid 43358070)